Plain-English translation of NCT03617133 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a modern approach to treating locally advanced cervical cancer using advanced imaging (MRI scans) to guide radiation therapy combined with weekly chemotherapy. The treatment combines external beam radiation (aimed at the cancer from outside the body) with internal radiation (brachytherapy, placed directly near the cancer), along with chemotherapy medication called Cisplatin. This newer method aims to improve cure rates and reduce side effects compared to older radiation techniques.
Large studies have shown that using MRI imaging to guide internal radiation therapy can significantly improve cancer control and survival in cervical cancer patients. This trial continues that research with a larger group of patients to confirm these benefits and better understand which patients benefit most from this treatment approach.
You likely qualify if…
You likely don't qualify if…
You will receive standard cervical cancer treatment combining external beam radiation therapy (given daily over several weeks), internal radiation therapy (brachytherapy, given in multiple sessions), and weekly chemotherapy injections. Your doctors will use repeated MRI scans to carefully plan and adjust your internal radiation treatment to match your specific cancer. The trial tracks your cancer control, survival, and any side effects over time to help improve treatment for future patients.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
Austria